Birch Hill Investment Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$333K Hold
5,782
0.01% 172
2026
Q1
$351K Hold
5,782
0.02% 163
2025
Q4
$312K Buy
5,782
+300
+5% +$14.4K 0.01% 169
2025
Q3
$247K Hold
5,482
0.01% 182
2025
Q2
$254K Hold
5,482
0.01% 181
2025
Q1
$334K Sell
5,482
-2,524
-32% -$147K 0.02% 158
2024
Q4
$453K Buy
8,006
+26
+0.3% +$1.45K 0.02% 143
2024
Q3
$413K Hold
7,980
0.02% 141
2024
Q2
$331K Sell
7,980
-851
-10% -$38.1K 0.02% 146
2024
Q1
$479K Sell
8,831
-666
-7% -$33.9K 0.02% 132
2023
Q4
$487K Sell
9,497
-8,894
-48% -$467K 0.03% 120
2023
Q3
$1.07M Sell
18,391
-57
-0.3% -$3.49K 0.06% 91
2023
Q2
$1.18M Hold
18,448
0.07% 87
2023
Q1
$1.28M Sell
18,448
-892
-5% -$62.9K 0.08% 86
2022
Q4
$1.39M Buy
19,340
+160
+0.8% +$12.1K 0.09% 86
2022
Q3
$1.36M Sell
19,180
-50
-0.3% -$3.63K 0.09% 84
2022
Q2
$1.48M Sell
19,230
-50
-0.3% -$3.81K 0.09% 84
2022
Q1
$1.41M Buy
19,280
+1,600
+9% +$107K 0.08% 91
2021
Q4
$1.1M Sell
17,680
-2,774
-14% -$163K 0.05% 96
2021
Q3
$1.21M Sell
20,454
-1,000
-5% -$65.9K 0.07% 93
2021
Q2
$1.43M Sell
21,454
-310
-1% -$20.2K 0.08% 86
2021
Q1
$1.37M Sell
21,764
-6,152
-22% -$383K 0.08% 85
2020
Q4
$1.73M Sell
27,916
-1,800
-6% -$111K 0.1% 77
2020
Q3
$1.79M Hold
29,716
0.12% 70
2020
Q2
$1.75M Sell
29,716
-450
-1% -$26.9K 0.13% 69
2020
Q1
$1.68M Sell
30,166
-16,690
-36% -$1.02M 0.15% 67
2019
Q4
$3.01M Buy
46,856
+37,808
+418% +$2.17M 0.2% 56
2019
Q3
$459K Sell
9,048
-500
-5% -$23.5K 0.03% 112
2019
Q2
$433K Hold
9,548
0.03% 116
2019
Q1
$456K Buy
+9,548
New +$476K 0.03% 114
2018
Q4
Sell
-10,714
Closed -$665K 138
2018
Q3
$665K Sell
10,714
-900
-8% -$53.4K 0.05% 106
2018
Q2
$643K Sell
11,614
-800
-6% -$43.2K 0.05% 100
2018
Q1
$785K Sell
12,414
-198
-2% -$12.7K 0.07% 86
2017
Q4
$773K Hold
12,612
0.06% 89
2017
Q3
$804K Buy
12,612
+1,300
+11% +$75.9K 0.07% 87
2017
Q2
$630K Hold
11,312
0.06% 91
2017
Q1
$615K Buy
11,312
+400
+4% +$21.9K 0.05% 90
2016
Q4
$638K Hold
10,912
0.06% 89
2016
Q3
$588K Buy
10,912
+1,000
+10% +$64.2K 0.05% 89
2016
Q2
$729K Buy
9,912
+100
+1% +$7.07K 0.07% 84
2016
Q1
$627K Sell
9,812
-1,500
-13% -$94.6K 0.07% 88
2015
Q4
$778K Sell
11,312
-100
-0.9% -$6.61K 0.08% 82
2015
Q3
$676K Hold
11,412
0.07% 88
2015
Q2
$759K Hold
11,412
0.08% 90
2015
Q1
$736K Sell
11,412
-240
-2% -$15K 0.08% 93
2014
Q4
$688K Hold
11,652
0.07% 94
2014
Q3
$596K Buy
11,652
+240
+2% +$12K 0.06% 96
2014
Q2
$554K Hold
11,412
0.06% 98
2014
Q1
$593K Buy
11,412
+500
+5% +$26.6K 0.06% 93
2013
Q4
$580K Hold
10,912
0.06% 103
2013
Q3
$505K Buy
10,912
+666
+7% +$29.2K 0.06% 103
2013
Q2
$458K Buy
+10,246
New +$445K 0.06% 105

Other funds holding BMY

Birch Hill Investment Advisors's BMY Position: Q2 2026 in Review

Birch Hill Investment Advisors held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 5,782 shares worth $333K. The position accounts for 0.01% of the portfolio, ranked #172.

Birch Hill Investment Advisors first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.01M in Q4 2019. 878 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Birch Hill Investment Advisors held 5,782 shares of Bristol-Myers Squibb worth $333K as of Q2 2026.
  • Birch Hill Investment Advisors left its Bristol-Myers Squibb share count unchanged in Q2 2026.
  • Bristol-Myers Squibb made up 0.01% of Birch Hill Investment Advisors's portfolio in Q2 2026, its #172 holding.
  • Birch Hill Investment Advisors first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • Birch Hill Investment Advisors's Bristol-Myers Squibb position peaked at $3.01M in Q4 2019.
  • 878 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Birch Hill Investment Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.